Literature DB >> 17053894

Comparative analysis of the effects of rice and bread meals on bioavailability of itraconazole using NONMEM in healthy volunteers.

Hwi-yeol Yun1, Min Sun Baek, In Sook Park, Bo Kyung Choi, Kwang-il Kwon.   

Abstract

OBJECTIVE: The objectives of this retrospective study were to examine the relationship between the bioavailability of itraconazole and the type of food consumed and to determine the effects of food consumption on the pharmacokinetic parameters following a single oral dose of itraconazole in healthy volunteers.
METHODS: The plasma itraconazole concentration-time data were pooled from four pharmacokinetic studies in 144 healthy subjects. Individual pharmacokinetic values were estimated as model-independent (AUC, C (max), and T (max)) and model-dependent (T (lag), K (a), K (cp), K (pc), K (el), and V (d)/F; two-compartment open model with lag time) parameters using the WinNonlin software program. We estimated the population characteristics of the food effects using NONMEM.
RESULTS: The consumption of a bread meal before the administration of itraconazole caused a significant increase in its bioavailability, as well as increases in the peak plasma concentration and lag time for itraconazole absorption. On the contrary, consumption of a rice meal before the administration of itraconazole caused a significant decrease in its bioavailability.
CONCLUSION: Therefore, although a dose of itraconazole is normally administered immediately after a meal to increase its bioavailability, this is not an effective strategy after a rice meal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053894     DOI: 10.1007/s00228-006-0200-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.

Authors:  Hwi-Yeol Yun; Eun Joo Lee; Soo Youn Chung; Sun-Ok Choi; Hyung Kee Kim; Jun-Tack Kwon; Wonku Kang; Kwang-Il Kwon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers.

Authors:  S R Penzak; P O Gubbins; B J Gurley; P L Wang; M Saccente
Journal:  Ther Drug Monit       Date:  1999-06       Impact factor: 3.681

3.  Itraconazole pharmacokinetics in patients with renal dysfunction.

Authors:  J Boelaert; M Schurgers; E Matthys; R Daneels; A van Peer; K De Beule; R Woestenborghs; J Heykants
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 4.  The triazole antifungal agents: a review of itraconazole and fluconazole.

Authors:  E M Bailey; D J Krakovsky; M J Rybak
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

Review 5.  The clinical pharmacokinetics of itraconazole: an overview.

Authors:  J Heykants; A Van Peer; V Van de Velde; P Van Rooy; W Meuldermans; K Lavrijsen; R Woestenborghs; J Van Cutsem; G Cauwenbergh
Journal:  Mycoses       Date:  1989       Impact factor: 4.377

6.  Absorption, first-pass metabolism, and disposition of itraconazole in rats.

Authors:  S D Yoo; E Kang; H Jun; B S Shin; K C Lee; K H Lee
Journal:  Chem Pharm Bull (Tokyo)       Date:  2000-06       Impact factor: 1.645

7.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

Review 8.  Optimisation of itraconazole therapy using target drug concentrations.

Authors:  J M Poirier; G Cheymol
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

9.  Itraconazole: pharmacology, clinical experience and future development.

Authors:  K De Beule
Journal:  Int J Antimicrob Agents       Date:  1996-02       Impact factor: 5.283

10.  Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies.

Authors:  Jia Woei Wong; Ur-Rahman Nisar; Kah Hay Yuen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-12-25       Impact factor: 3.205

View more
  6 in total

1.  Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Stuart Mudge; David Hayes; Richard N Upton
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

2.  Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug-Drug Interaction Prediction.

Authors:  Yuan Chen; Fang Ma; Tong Lu; Nageshwar Budha; Jin Yan Jin; Jane R Kenny; Harvey Wong; Cornelis E C A Hop; Jialin Mao
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

3.  Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.

Authors:  Ahmad Y Abuhelwa; Stuart Mudge; David Hayes; Richard N Upton; David J R Foster
Journal:  Pharm Res       Date:  2016-04-27       Impact factor: 4.200

4.  Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions.

Authors:  Adriana M Rauseo; Patrick Mazi; Phoebe Lewis; Bruce Burnett; Stuart Mudge; Andrej Spec
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

5.  Influence of Gender, Body Mass Index, and Age on the Pharmacokinetics of Itraconazole in Healthy Subjects: Non-Compartmental Versus Compartmental Analysis.

Authors:  Milijana N Miljković; Nemanja Rančić; Aleksandra Kovačević; Bojana Cikota-Aleksić; Ivan Skadrić; Vesna Jaćević; Momir Mikov; Viktorija Dragojević-Simić
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

6.  A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption.

Authors:  Hyun-Moon Back; Byungjeong Song; Sudeep Pradhan; Jung-Woo Chae; Nayoung Han; Wonku Kang; Min Jung Chang; Jiao Zheng; Kwang-Il Kwon; Mats O Karlsson; Hwi-Yeol Yun
Journal:  BMC Pharmacol Toxicol       Date:  2018-01-25       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.